Doctors Tell FDA to Regulate Robotic Surgery Cautiously in Anticipation of Competitors to da Vinci
Written By: Rheingold, Giuffra, Ruffo & Plotkin LLP
Experts weighed in at FDA headquarters to confer about the opportunities posed by robotic surgery, as well as the foreseeable challenges. Discussion also centered on how the agency should regulate devices and tools that enable the new treatment model.
Intuitive Surgical'sda Vinci robotic surgery platform is the only device of its kind currently on the market, although the FDA says competitors are approaching.
The da Vinci is a massive, magnified 3D high-definition vision system, with tiny wristed instruments that bend and rotate far greater than the human wrist. As a result, the da Vinci enables a surgeon to operate with enhanced vision, precision, dexterity, and control.
With nearly 600,000 procedures performed using the device in 2014 (previous at 200,000 in 2009), the da Vinci is transforming patient care in disciplines such as urology and gynecology.
However, the da Vinci system did face several setbacks leading to a slew of lawsuits. The system also faced a recall in 2013. If you or someone you know was injured during a robotics surgery contact us today at 212-684-1880 or online.